Literature DB >> 30765940

Long Term Survival of Patients Undergoing TIPS in Budd-Chiari Syndrome.

Amey D Sonavane1, Deepak N Amarapurkar2, Krantikumar R Rathod3, Sundeep J Punamiya4.   

Abstract

BACKGROUND: There has been significant improvement in understanding the etiology and management of Budd-Chiari Syndrome (BCS). Patients with chronic or acute-on-chronic BCS need radiological interventions in the form of angioplasty, hepatic vein/inferior vena cava stenting or Transjugular Intrahepatic Portosystemic Shunt (TIPS). Data regarding the long term follow up of patients undergoing TIPS is limited. We thus prospectively followed-up BCS patients who underwent TIPS at our center.
METHODS: This study included 42 patients with BCS who underwent TIPS with a covered stent between 2004 and 2014. We analyzed the etiology, symptoms, severity, laboratory parameters and imaging pre and post TIPS. All patients underwent surveillance for hepatocellular carcinoma.
RESULTS: Patients demographics included 26 males and 16 females with a mean age of 40.5 years (19-68 years). The mean Model for End-Stage Liver Disease score of the entire cohort was 15.38 (range: 9-25). Thirty-four patients were grouped into Rotterdam Class 2 and remaining into Class 3. There was significant improvement in ascites, gastrointestinal bleed, renal function and transaminase levels post TIPS. There were 11 deaths over the follow-up period - 4 within one month, 2 within six months and the rest after 3 years following TIPS. Median duration from clinical presentation to TIPS was 2.1 weeks and median survival till follow-up was 45.5 months (0-130 months). 33/42 patients underwent TIPS prior to 2013, and their median survival till follow-up was 55 months. Six out of eleven deaths that occurred within six months post-TIPS were before 2006; when the technique of TIPS creation was evolving. The cumulative 1 year, 5 years and 10 years OLT-free survival was 86%, 81% and 76%, respectively. Two patients underwent a liver transplant at 4 and 7 years after TIPS.
CONCLUSION: Our results validate the role of TIPS in the management of patients with BCS. With the accessibility of TIPS, the requirement for liver transplantation has become rare.

Entities:  

Keywords:  AT III, Antithrombin III; BCS, Budd-Chiari Syndrome; Budd Chiari syndrome; CT, Computerized Tomography; CTP, Child-Turcotte-Pugh; HV, Hepatic Vein; INR, International Normalized Ratio; IVC, Inferior Vena Cava; JAK-2, Janus Kinase 2; MELD, Model for End-Stage Liver Disease; MRI, Magnetic Resonance Imaging; MTHFR, Methylene Tetrahydrofolate Reductase; OLT, Orthotopic Liver Transplantation; SD, Standard Deviation; TIPS, Transjugular Intrahepatic Portosystemic Shunt; TIPS-BCS PI score, BCS-TIPS Prognostic Index score; long term survival; orthotopic liver transplantation free survival; transjugular intrahepatic portosystemic shunt

Year:  2018        PMID: 30765940      PMCID: PMC6363956          DOI: 10.1016/j.jceh.2018.02.008

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  19 in total

1.  A new technique of side to side caval anastomosis during orthotopic hepatic transplantation without inferior vena caval occlusion.

Authors:  J Belghiti; Y Panis; A Sauvanet; B Gayet; F Fékété
Journal:  Surg Gynecol Obstet       Date:  1992-09

2.  Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome.

Authors:  C E Eapen; D Velissaris; M Heydtmann; B Gunson; S Olliff; E Elias
Journal:  Gut       Date:  2005-09-20       Impact factor: 23.059

3.  Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2005-07       Impact factor: 25.083

4.  Budd-Chiari syndrome: current management options.

Authors:  D P Slakey; A S Klein; A C Venbrux; J L Cameron
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

5.  Management of Budd-Chiari syndrome.

Authors:  Andrew S Klein
Journal:  Liver Transpl       Date:  2006-11       Impact factor: 5.799

6.  Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems.

Authors:  D R Ganger; J B Klapman; V McDonald; T A Matalon; S Kaur; H Rosenblate; R Kane; M Saker; D M Jensen
Journal:  Am J Gastroenterol       Date:  1999-03       Impact factor: 10.864

7.  TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy.

Authors:  Antonia Perelló; Juan Carlos García-Pagán; Rosa Gilabert; Yanette Suárez; Eduardo Moitinho; Francisco Cervantes; Juan Carlos Reverter; Angels Escorsell; Jaume Bosch; Juan Rodés
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

8.  The utility of TIPS in the management of Budd-Chiari syndrome.

Authors:  Ernesto P Molmenti; Dorry L Segev; Aravind Arepally; Jenny Hong; Paul J Thuluvath; Rudra Rai; Andrew S Klein
Journal:  Ann Surg       Date:  2005-06       Impact factor: 12.969

9.  TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience.

Authors:  Andrea Mancuso; Konrad Fung; Maria Mela; John Tibballs; Anthony Watkinson; Andrew K Burroughs; David Patch
Journal:  J Hepatol       Date:  2003-06       Impact factor: 25.083

10.  The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt.

Authors:  Martin Rössle; Manfred Olschewski; Volker Siegerstetter; Elisabeth Berger; Katharina Kurz; Daniel Grandt
Journal:  Surgery       Date:  2004-04       Impact factor: 3.982

View more
  4 in total

1.  A Case of Budd-Chiari Syndrome Associated With Antiphospholipid Syndrome Treated Successfully by Transjugular Intrahepatic Portosystemic Shunt.

Authors:  Ege Sinan Torun; Mert Erciyestepe; Yasemin Yalçınkaya; Ahmet Gül; Murat İnanç; Lale Öcal; Sabahattin Kaymakoğlu; Bora Peynircioğlu; Bahar Artım-Esen
Journal:  Clin Med Insights Case Rep       Date:  2022-05-18

Review 2.  State of the Art, Current Perspectives, and Controversies of Budd-Chiari Syndrome: A Review.

Authors:  Paschalis Gavriilidis; Gabriele Marangoni; Jawad Ahmad; Daniel Azoulay
Journal:  J Clin Med Res       Date:  2022-04-30

3.  Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis.

Authors:  Gauri Mukhiya; Xueliang Zhou; Xinwei Han; Dechao Jiao; Gaurab Pokhrel; Yahua Li; Sita Pokhrel
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

Review 4.  Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: A comprehensive review.

Authors:  Riccardo Inchingolo; Alessandro Posa; Martin Mariappan; Tiago Kojun Tibana; Thiago Franchi Nunes; Stavros Spiliopoulos; Elias Brountzos
Journal:  World J Gastroenterol       Date:  2020-09-14       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.